With the help of a $2.7 million grant from the U.S. Army Medical Research and Materiel Command, Genocea Biosciences will collaborate with the Naval Medical Research Center to identify antigens that will be used to develop a vaccine candidate against Plasmodium falciparum for the prevention of malaria. Genocea release